FDA Authorizes First SARS-CoV-2 Antibody Test That Can be Performed at the Point of Care
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
With 47 COVID-19 antibody tests authorized for use under FDA EUA as of Sept. 24, 2020, only one is authorized as POC for fingerstick blood samples collected in patient care settings.